Short Interest in Polyrizon Ltd. (NASDAQ:PLRZ) Drops By 26.4%

Polyrizon Ltd. (NASDAQ:PLRZ) was the target of a large decrease in short interest in December. As of December 31st, there was short interest totaling 129,601 shares, a decrease of 26.4% from the December 15th total of 176,028 shares. Approximately 12.4% of the shares of the stock are short sold. Based on an average daily volume of 90,970 shares, the short-interest ratio is currently 1.4 days. Based on an average daily volume of 90,970 shares, the short-interest ratio is currently 1.4 days. Approximately 12.4% of the shares of the stock are short sold.

Polyrizon Stock Performance

Shares of NASDAQ PLRZ traded up $0.01 during trading hours on Friday, reaching $15.55. 50,023 shares of the stock traded hands, compared to its average volume of 154,303. The company’s 50-day simple moving average is $8.81 and its two-hundred day simple moving average is $7.23. Polyrizon has a 52-week low of $2.88 and a 52-week high of $2,550.00.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on PLRZ shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Polyrizon in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of Polyrizon from a “strong sell” rating to a “hold” rating in a research report on Saturday, September 20th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Polyrizon has an average rating of “Sell”.

About Polyrizon

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.